NRXS NeurAxis, Inc.
NeurAxis, Inc. (NRXS) is expected to report earnings on February 8, 2027, before the market open. The consensus earnings estimate is a loss of $0.21 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -12.4% since its last earnings release on November 9, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About NeurAxis, Inc.
NeurAxis, Inc. is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis, Inc. is based in CARMEL, Ind.
Charts powered in part by Lightweight Charts™ by TradingView.